
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Birmingham, England - Uncomplicated hemangiomas that clear well with a pulsed dye laser (PDL) are probably limited to superficial lesions that would have resolved without treatment, according to Kapila Batta, M.D.






